Zaloguj Zarejestruj się zadarmo

IMV organizacji Dochody

Jaka jest wartość Dochody organizacji IMV?

Wartość Dochody organizacji IMV, Inc. to -$41.10

Jaka jest definicja Dochody?

Dochód netto dostępny dla zwykłych akcjonariuszy jest równy dochodzie netto pomniejszonemu o wypłatę uprzywilejowanych dywidend.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Dochody firm w Health Care sektor na TSX w porównaniu do IMV

Czym się zajmuję organizacja IMV?

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Firmy z dochody podobne do IMV